Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nadal

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphomaToshihiro Nagato, Seigo Ueda, Miki Takahara, et al.
European Journal of Pediatrics|December 13, 2007
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritisThomas J Neuhaus, Christoph Berger, Katja Buechner, et al.
International Journal of Cancer|May 4, 2013
Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseasesMichele Bernasconi, Seigo Ueda, Patricia Krukowski, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 19, 2019
Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trialsLucia Ruggieri, Donato Bonifazi, Annalisa Landi, et al.
Infection Control and Hospital Epidemiology|October 16, 2004
Prevalence of nosocomial infections in Swiss children's hospitalsKathrin Mühlemann, Christine Franzini, Christoph Aebi, et al.
Current Infectious Disease Reports|April 29, 2015
The swiss transplant cohort study: lessons from the first 6 yearsChristoph Berger, Pierre-Yves Bochud, Katja Boggian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort StudyChristian van Delden, Susanne Stampf, Hans H Hirsch, et al.
Plos Pathogens|May 31, 2019
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivoBithi Chatterjee, Yun Deng, Angelika Holler, et al.
Swiss Medical Weekly|December 7, 2016
Update of the Swiss guidelines on post-treatment Lyme disease syndromeJohannes Nemeth, Enos Bernasconi, Ulrich Heininger, et al.
The Lancet. Child & Adolescent Health|June 5, 2020
39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trialChrista Koenig, Nicole Bodmer, Philipp K A Agyeman, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphomaToshihiro Nagato, Seigo Ueda, Miki Takahara, et al.
European Journal of Pediatrics|December 13, 2007
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritisThomas J Neuhaus, Christoph Berger, Katja Buechner, et al.
International Journal of Cancer|May 4, 2013
Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseasesMichele Bernasconi, Seigo Ueda, Patricia Krukowski, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 19, 2019
Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe-wide trialsLucia Ruggieri, Donato Bonifazi, Annalisa Landi, et al.
Infection Control and Hospital Epidemiology|October 16, 2004
Prevalence of nosocomial infections in Swiss children's hospitalsKathrin Mühlemann, Christine Franzini, Christoph Aebi, et al.
Current Infectious Disease Reports|April 29, 2015
The swiss transplant cohort study: lessons from the first 6 yearsChristoph Berger, Pierre-Yves Bochud, Katja Boggian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort StudyChristian van Delden, Susanne Stampf, Hans H Hirsch, et al.
Plos Pathogens|May 31, 2019
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivoBithi Chatterjee, Yun Deng, Angelika Holler, et al.
Swiss Medical Weekly|December 7, 2016
Update of the Swiss guidelines on post-treatment Lyme disease syndromeJohannes Nemeth, Enos Bernasconi, Ulrich Heininger, et al.
The Lancet. Child & Adolescent Health|June 5, 2020
39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trialChrista Koenig, Nicole Bodmer, Philipp K A Agyeman, et al.
Pageof 11